| Name |
Deksametazon Medochemie 4 mg/ml otopina za injekciju/infuziju |
| Marketing Authorisation Number |
HR-H-746260380 |
| Active Substance |
natrijev deksametazonfosfat |
| Composition |
svaka ampula s 1 ml otopine sadrži 4 mg deksametazonfosfata (u obliku natrijevog deksametazonfosfata) svaka ampula s 2 ml otopine sadrži 8 mg deksametazonfosfata (u obliku natrijevog deksametazonfosfata) |
| Pharmaceutical Form |
Otopina za injekciju / infuziju |
| Manufacturer |
Medochemie Ltd., Agios Athanasios, Limassol, Cipar |
| Marketing Authorisation Holder |
Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
| Marketing Authorisation Date |
06.04.2023 |
| MA Period of Validity |
06.04.2028 |
| Classification Number |
UP/I-530-09/21-01/153 |
| Registration Number |
381-12-01/38-23-07 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
H02AB02 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|